Objective: The investment objective of the scheme is to provide investment returns closely corresponding to the total returns of the securities as represented by the NIFTY Pharma Index before expenses, subject to tracking errors. However, there can be no assurance or guarantee that the investment objective of the Scheme will be achieved.
Nippon India Nifty Pharma ETF is an Equity - Sector - Healthcare fund. The fund was launched inJul 06, 2021. Its risk level is . The NAV of the fund as onDec 24, 2025 is ₹23.31. Its expense ratio is 0.21 %. The fund has an AUM of ₹1,033.98 Cr.The fund is managed byMehul Dama,Himanshu Mange,Jitendra Tolani.
The minimum initial investment is --









